Processing
News
-
Demaris Mills Appointed President of IDT
-
Editas Medicine and IDT Announce Publication in Nature Communications of Research Data Supporting the Use of Optimized AsCas12a Nuclease Variant, Alt-R A.s. Cas12a (Cpf1) Ultra, in Researching the Potential of Gene-Edited Cell Medicines
-
Predicine Joins IDT Align Program
-
Geneseeq Joins IDT Align Program
-
Psomagen Added to IDT Align Program
-
IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical Research
-
IDT Launches rhAmpSeq™ CRISPR Analysis System
-
IDT Continues Support of iGEM to Promote Next Generation of Synthetic Biology Researchers and Leaders
-
IDT Expands Global Footprint with Launch of IDT China
-
Novogene America Joins IDT Align Preferred Sequencing Partner Program
-
IDT offers powerful new NGS tools for COVID-19 research
-
IDT launches gBlocks™ HiFi, improving on industry-leading products for synthetic biology
-
IDT broadens capacity and customer support of COVID-19 products with new manufacturing facility
-
IDT announces expansion of coronavirus products, begins accepting pre-orders for new COVID-19 primer-probe panel in ratios set forth in WHO-Charité/Berlin test
-
IDT achieves large-scale manufacturing success of key COVID-19 test component
-
IDT launches Alt-R™ HDR Design Tool and Templates
-
IDT launches xGen™ Prism DNA Library Prep Kit
-
IDT offers preferred pricing and early access to complete portfolio of coronavirus research tools
-
IDT launches xGen™ Exome Research Panel v2
-
IDT partners with SOPHiA GENETICS to increase access to clinical-grade technologies
- 1 (current)
- 2
- 3
- 4
- 5
Media and PR
For media inquiries please contact IDT Public Relations, idtpr@idtdna.com